rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-5-15
|
pubmed:abstractText |
Local recurrence occurs in 10% to 20% of patients with extremity soft tissue sarcomas despite optimal treatment. The association of local recurrence with subsequent survival is controversial and conflicting. There is a need for a staging system to predict outcome in this subset of patients and also to plan optimal treatment, including adjuvant systemic therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1068-9265
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
278-89
|
pubmed:dateRevised |
2007-7-18
|
pubmed:meshHeading |
pubmed-meshheading:11352300-Adolescent,
pubmed-meshheading:11352300-Adult,
pubmed-meshheading:11352300-Aged,
pubmed-meshheading:11352300-Aged, 80 and over,
pubmed-meshheading:11352300-Child,
pubmed-meshheading:11352300-Disease-Free Survival,
pubmed-meshheading:11352300-Female,
pubmed-meshheading:11352300-Humans,
pubmed-meshheading:11352300-Male,
pubmed-meshheading:11352300-Middle Aged,
pubmed-meshheading:11352300-Neoplasm Invasiveness,
pubmed-meshheading:11352300-Neoplasm Recurrence, Local,
pubmed-meshheading:11352300-Neoplasm Staging,
pubmed-meshheading:11352300-Prognosis,
pubmed-meshheading:11352300-Retrospective Studies,
pubmed-meshheading:11352300-Sarcoma,
pubmed-meshheading:11352300-Soft Tissue Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
|
pubmed:affiliation |
Royal Marsden Hospital, London, United Kingdom. ramanathanrc@msx.upmc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|